GlassScriptPhysician profile
Mallory Boyle
NPI 1669187902
$2,243.90
in general payments reported to CMS, 2019-2025
19 companies · $1,465 in 2025
The $1,465 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $431 · 2024: $348 · 2025: $1,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,033 · Education: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,032.88 |
| Education | $211.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $846.79 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $230.48 | 2023-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $195.65 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $161.37 | 2025 | Sotyktu |
| Ucb, INC. | $106.72 | 2025 | Bimzelx |
| Janssen Biotech, INC. | $104.00 | 2023 | Tremfya |
| Sun Pharmaceutical Industries INC. | $85.52 | 2024-2025 | |
| Organon LLC | $75.48 | 2025 | Vtama |
| Amgen INC. | $74.93 | 2024-2025 | Otezla, Otezla |
| Leo Pharma INC. | $64.21 | 2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $62.81 | 2024-2025 | Taltz, Ebglyss |
| Genzyme Corporation | $62.36 | 2024-2025 | |
| Galderma Laboratories, L.P. | $50.99 | 2024-2025 | Nemluvio |
| Pfizer INC. | $47.16 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.48 | 2025 | Cabtreo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $15.57 | 2025 | |
| Botanix Sb INC | $15.32 | 2025 | Sofdra |
| Fresenius Kabi USA, LLC | $14.11 | 2024 | Idacio |
| Dermavant Sciences, INC. | $13.95 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Boyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.